Bridget E. Bunner

Array ( [id] => 724771 [patent_doc_number] => 07045531 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-16 [patent_title] => 'Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator' [patent_app_type] => utility [patent_app_number] => 09/380704 [patent_app_country] => US [patent_app_date] => 1998-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 60 [patent_no_of_words] => 40750 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/045/07045531.pdf [firstpage_image] =>[orig_patent_app_number] => 09380704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6032020 [patent_doc_number] => 20020018763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'A METHOD OF STIMULATING GROWTH OF STROMAL CELLS WITH STEM CELL FACTOR (SCF) POLYPEPTIDES' [patent_app_type] => new [patent_app_number] => 09/005243 [patent_app_country] => US [patent_app_date] => 1998-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 119 [patent_figures_cnt] => 119 [patent_no_of_words] => 52519 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20020018763.pdf [firstpage_image] =>[orig_patent_app_number] => 09005243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1235383 [patent_doc_number] => 06689579 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-10 [patent_title] => 'Polynucleotides encoding neutrokine- ' [patent_app_type] => B1 [patent_app_number] => 09/005874 [patent_app_country] => US [patent_app_date] => 1998-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27990 [patent_no_of_claims] => 194 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689579.pdf [firstpage_image] =>[orig_patent_app_number] => 09005874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1531863 [patent_doc_number] => 06410268 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Polynucleotides encoding chemokine alpha-3' [patent_app_type] => B1 [patent_app_number] => 08/816772 [patent_app_country] => US [patent_app_date] => 1997-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19845 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410268.pdf [firstpage_image] =>[orig_patent_app_number] => 08816772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1024039 [patent_doc_number] => 06884411 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-04-26 [patent_title] => 'Method of treating viral hepatitis by administration of liquid human α-interferon' [patent_app_type] => utility [patent_app_number] => 09/125122 [patent_app_country] => US [patent_app_date] => 1997-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4122 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/884/06884411.pdf [firstpage_image] =>[orig_patent_app_number] => 09125122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1565264 [patent_doc_number] => 06376214 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'DNA encoding a novel homolog of CSBP/p38 MAP kinase' [patent_app_type] => B1 [patent_app_number] => 08/802191 [patent_app_country] => US [patent_app_date] => 1997-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 1 [patent_no_of_words] => 10353 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376214.pdf [firstpage_image] =>[orig_patent_app_number] => 08802191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7615229 [patent_doc_number] => 06897295 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-24 [patent_title] => 'Antibodies and fragments thereof to Fas ligand and Fas ligand derived polypeptides' [patent_app_type] => utility [patent_app_number] => 08/683703 [patent_app_country] => US [patent_app_date] => 1996-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 44 [patent_no_of_words] => 40451 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/897/06897295.pdf [firstpage_image] =>[orig_patent_app_number] => 08683703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1275660 [patent_doc_number] => 06645493 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-11 [patent_title] => 'Composition containing anti-MIF antibody' [patent_app_type] => B1 [patent_app_number] => 08/471705 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 28 [patent_no_of_words] => 31081 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/645/06645493.pdf [firstpage_image] =>[orig_patent_app_number] => 08471705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1553282 [patent_doc_number] => 06348334 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-19 [patent_title] => 'DNA encoding Fas ligand' [patent_app_type] => B1 [patent_app_number] => 08/339214 [patent_app_country] => US [patent_app_date] => 1994-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 46 [patent_no_of_words] => 55602 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/348/06348334.pdf [firstpage_image] =>[orig_patent_app_number] => 08339214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6762157 [patent_doc_number] => 20030125519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'LIGAND FOR THE C-KIT RECEPTOR AND METHODS OF USE THEREOF' [patent_app_type] => new [patent_app_number] => 07/594306 [patent_app_country] => US [patent_app_date] => 1990-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16952 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125519.pdf [firstpage_image] =>[orig_patent_app_number] => 07594306 [rel_patent_id] =>[rel_patent_doc_number] =>)